We offer a range of teaming and licensing arrangements that make our expertise, technology, and intellectual property (IP) available to partners.
Evident owns or has an exclusive license to over 60 issued, pending, and provisional US and foreign filings. This patent portfolio encompasses various aspects of semiconductor nanocrystal technologies from synthesis to application. The Evident IP portfolio extends to applications such as biological testing, light emitting diodes, optoelectronics, inks, paints, solar cells, personal care products, and optical switching. Additional applications are being developed and added to Evident's expanding IP portfolio.
To learn more about our intellectual property, licensing opportunities, and the competitive advantage of using our material systems to develop new products please contact us at 518-273-6266 or complete the form below.